Description
Relvar Ellipta combines fluticasone furoate, an inhaled corticosteroid, with vilanterol, a long-acting beta-2 agonist, in a dry powder device. The steroid reduces the inflammation that underlies asthma and vilanterol relaxes the muscle around the airways, and the pair last long enough to be taken once a day. It is used as regular treatment for asthma, and the lower strength is also used in chronic obstructive pulmonary disease.
It is not a reliever and does not treat a sudden attack; keep a short-acting reliever inhaler for that. Open the cover to load a dose, breathe in steadily and deeply through the mouthpiece, then close the cover; opening the cover without inhaling wastes a dose. Rinse your mouth with water afterwards. Tell your prescriber if you have heart rhythm problems, thyroid disease, diabetes, liver problems or a history of tuberculosis.
- Combination inhaler: fluticasone furoate with vilanterol
- Inhaled corticosteroid plus long-acting beta-2 agonist (LABA)
- Dry powder Ellipta device, taken once daily
- Supplied as 92/22mcg and 184/22mcg per inhalation
- Not a reliever; keep a short-acting inhaler for sudden symptoms
- Rinse your mouth with water after each dose
